The rare street protests that erupted in cities across China over the weekend were a referendum against President Xi Jinping's zero-COVID policy and the strongest public defiance during his political career, China analysts said.
From his Portuguese home, Ai Weiwei, the high-profile Chinese dissident whose art has often criticized Beijing's policies, said the recent wave of protests would not shake Xi Jinping's government because the police would simply crush them into silence.
Siemens Healthineers on Monday announced an agreement to sell more than $140 million dollars of medical equipment to U.S. healthcare provider Atrium Health over the next 10 years in an effort to increase access to care in underserved communities.
Police on Monday stopped and searched people at the sites of weekend protests in Shanghai and Beijing, after crowds there and in other Chinese cities demonstrated against stringent COVID-19 measures disrupting lives three years into the pandemic.
The number of diphtheria cases in England has risen this year, health officials said on Monday, citing dozens of cases found among asylum seekers arriving into the country, but adding that the risk of infection to the wider public remained very low.
The World Health Organization said on Monday it would start using a new preferred term, "mpox", as a synonym for monkeypox and urged others to follow suit after receiving complaints that the current name for the disease was racist and stigmatising.
Germany is working to ensure cooperation between BioNTech and its Chinese partner on the COVID-19 vaccine moves forward, a German government spokesperson said on Monday.
China's capital city Beijing reported 2,086 new local COVID cases for the 15 hours to 3 p.m. (0700 GMT) on Monday, Liu Xiaofeng, the deputy director of the city's municipal Center for Disease Control and Prevention, said at a briefing.
British drug discovery company C4X Discovery said AstraZeneca had signed a licence worth up $402 million to develop an oral therapy for the treatment of inflammatory and respiratory diseases using its NRF2 Activator programme.
